Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$8,594,000
+$4,375,316 QoQ
Shares Held
243,043
+61.2% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Sep 30, 2021CallValue
$0
CallShares
0
PutValue
$388,584
PutShares
12,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $92,308,096 across 12 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
48,964 | $29,034,672 | |
| 2 | ZTS |
Zoetis Inc.
|
190,415 | $22,508,957 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
149,631 | $19,712,387 | |
| 4 | ALKS |
Alkermes plc.
This page
|
243,043 | $8,594,000 | |
| 5 | HLN |
Haleon plc
|
421,051 | $4,214,720 | |
| 6 | PRGO |
PERRIGO Co plc
|
277,003 | $2,975,012 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
29,715 | $1,535,968 | |
| 8 | LQDA |
Liquidia Corp
|
34,222 | $1,291,538 |
All Filings in ALKS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,594,000 | 243,043 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,218,684 | 150,775 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,628,770 | 120,959 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,142,368 | 39,929 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $4,704,589 | 163,581 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,810,665 | 279,052 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,216,763 | 257,957 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,906,119 | 144,297 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $651,362 | 23,481 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,967,812 | 141,657 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,182,685 | 165,581 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,795,143 | 241,048 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,818,504 | 375,756 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,976,691 | 267,653 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,217,956 | 175,158 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,847,014 | 70,202 | Shares | Sole | 2022-05-12 | |
| 2021-09-30 | $388,584 | 12,600 | Put | Sole | 2021-11-12 | |
| 2020-06-30 | $711,512 | 36,657 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $465,304 | 32,268 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||